Tag: CBT > Cannabis Schedule III: Page 7

Cannabis Rescheduling

US Congressman Urges DEA to Expedite Rescheduling Cannabis

Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”

January 5, 2024

Florida

5 Cannabis Policy Reform Efforts to Watch in 2024

From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.

December 27, 2023

Colorado

6 Governors Push Biden to Reschedule Cannabis Before Year’s End

Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.

December 6, 2023

Interviews & Opinion

Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit

After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."

November 22, 2023

Cannabis Rescheduling

US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III

The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”

November 21, 2023

Massachusetts

Another Path to Challenge Federal Cannabis Prohibition

Massachusetts cannabis operators and lawyers who filed a lawsuit against the U.S. attorney general over the enforcement of the Controlled Substances Act say they can’t wait—or count on—legislative action for relief.

November 17, 2023

Interviews & Opinion

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

November 7, 2023

Cannabis Rescheduling

31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition

A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”

November 1, 2023

Cannabis Rescheduling

‘There Will Be Wind in Our Sails’

September 26, 2023

Cannabis Rescheduling

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 26, 2023

Interviews & Opinion

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

September 20, 2023

Cannabis Industry Research

The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar

Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.

September 12, 2023